100-μm depth chamber slide Search Results


eyepiece microruler  (Klarmann Rulings)
90
Klarmann Rulings eyepiece microruler
Eyepiece Microruler, supplied by Klarmann Rulings, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/eyepiece+microruler/pmc02914362-111-26-32
Average 90 stars, based on 1 article reviews
eyepiece microruler - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
sliding microtome microm hm 400  (Microm International GmbH)
90
Microm International GmbH sliding microtome microm hm 400
Sliding Microtome Microm Hm 400, supplied by Microm International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/cryostat+microm+hm550/pmc03046330-166-11-12
Average 90 stars, based on 1 article reviews
sliding microtome microm hm 400 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
gelatin-coated slides  (FD NeuroTechnologies)
90
FD NeuroTechnologies gelatin-coated slides
Gelatin Coated Slides, supplied by FD NeuroTechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/gelatin+coated+slides/pmc09986217-496-23-25
Average 90 stars, based on 1 article reviews
gelatin-coated slides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
merscope slides  (Vizgen Inc)
86
Vizgen Inc merscope slides
Merscope Slides, supplied by Vizgen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/merscope+vizgen+%E2%80%A2/pmc13007250-405-13-15
Average 86 stars, based on 1 article reviews
merscope slides - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
microfluidic parallel platelet flow chamber  (ibidi GmbH)
90
ibidi GmbH microfluidic parallel platelet flow chamber
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Microfluidic Parallel Platelet Flow Chamber, supplied by ibidi GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/microfluidic+parallel+platelet+flow+chamber/pmc09116608-253-31-55
Average 90 stars, based on 1 article reviews
microfluidic parallel platelet flow chamber - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
glass slides  (Fisher Scientific)
86
Fisher Scientific glass slides
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Glass Slides, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/plus+slides+superfrost/us12648892-183-24-32
Average 86 stars, based on 1 article reviews
glass slides - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
heart organoid medium  (Thermo Fisher)
99
Thermo Fisher heart organoid medium
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Heart Organoid Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/Transferrin/pmc07471119-272-33-70
Average 99 stars, based on 1 article reviews
heart organoid medium - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
glass slides  (StatLab Medical Products Inc)
96
StatLab Medical Products Inc glass slides
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Glass Slides, supplied by StatLab Medical Products Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/Millennia+1000+Slides/pmc11192438-110-13-16
Average 96 stars, based on 1 article reviews
glass slides - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
polyimide tubing  (Neuralynx inc)
90
Neuralynx inc polyimide tubing
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Polyimide Tubing, supplied by Neuralynx inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/polyimide+tubes/pm39130131-130-10-13
Average 90 stars, based on 1 article reviews
polyimide tubing - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
glass slides corning  (Corning Life Sciences)
90
Corning Life Sciences glass slides corning
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Glass Slides Corning, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/corning+glass+slides/10__1002_slash_admt__201700279-170-20-23
Average 90 stars, based on 1 article reviews
glass slides corning - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
5 fu  (Selleck Chemicals)
96
Selleck Chemicals 5 fu
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
5 Fu, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/Fluorouracil/pm37778684-113-24-27
Average 96 stars, based on 1 article reviews
5 fu - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
microchamber slide htr1099  (VitroCom Inc)
90
VitroCom Inc microchamber slide htr1099
( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a <t>microfluidic</t> flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).
Microchamber Slide Htr1099, supplied by VitroCom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/100-%CE%BCm+depth+chamber+slide/flat+100+mm+deep+microslides+htr1099/pmc03381132-110-15-17
Average 90 stars, based on 1 article reviews
microchamber slide htr1099 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a microfluidic flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).

Journal: Science Advances

Article Title: Reduced platelet forces underlie impaired hemostasis in mouse models of MYH9 -related disease

doi: 10.1126/sciadv.abn2627

Figure Lengend Snippet: ( A ) Lysis onset time (LOT) and lysis time (LT) assessed with rotational thromboelastometry (ROTEM) without treatment (−), stimulation with rtPA, and after the addition of TXA to contrast rtPA-induced lysis stimulation. Overlapping of the modified ROTEM analysis curves (green, no treatment; red, rtPA stimulation; blue, rtPA and TXA stimulation). ( B ) Representative fluorescence images of human platelet thrombi (CD61; green) and fibrin (magenta) at 20 min after treatment in a microfluidic flow chamber at a shear of 100 s −1 (scale bars, 50 μm). ( C ) Time course of changes in stability of fibrin/-ogen (normalized fluorescence of fibrin/-ogen AF647; mean ± SD) on sites of platelet thrombi after the addition of TXA (100 μM) compared to nontreated control. ( D ) Whole blood from healthy individuals and an MYH9 p.D1424N patient was examined (untreated, with rtPA, with TXA, and with TXA + rtPA) using colloidal probe spectroscopy. Each data point shows the median Young’s modulus of one healthy individual or MYH9 p.D1424N aggregate, and bar plots show means ± SD of Young’s modulus. Statistics: Mann-Whitney U test (ns, P ≥ 0.05; *0.05 > P ≥ 0.01; and *** P < 0.001).

Article Snippet: Ex vivo thrombus formation assays were performed at a wall shear rate of 1000 s −1 on collagen-passivated surfaces [Horm collagen type I (200 μg/ml) from horse tendon; Nycomed] in a microfluidic parallel platelet flow chamber (on μ-Slide VI 0.1 with the following physical dimensions: width, 1 mm; height, 100 μm; and length, 17 mm; ibidi GmbH, Germany).

Techniques: Lysis, Modification, Fluorescence, Shear, Control, Spectroscopy, MANN-WHITNEY